| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c97f90ab12b35b650d5fd039ed7a41a5 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate |
2017-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c2bd8b04fed2355e60db9075682665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e204c6082c1725e46ff92bbe92438d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70d6535094169405e9099256ab8cf94c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7372f003b6879d55784355a85d043559
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8b48f5fa1c9fe0a350d2f96b45616aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca1975bf927ea30e75160b2d40a36751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f45928300dfb0cdd29128d6dda04a519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6db4c7736b8ccb4648e72bea9880380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bcf750de69515f0b890d04f25203e4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_955e80f39cac2834e9348ee763ffdf2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ab1f50aec2c11348b2ac2d7e8b3c0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_310aea53854d8b4eef916885685aa80d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbaf1b057aa99a47f4a75675c379083b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_284a35fc7bf20f13ea9da104b016a7be |
| publicationDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018084568-A |
| titleOfInvention |
Test support method for supporting prediction of pathological complete response (pCR) using fluorescent nanoparticles |
| abstract |
Sample collected from breast cancer patients undergoing preoperative chemotherapy (tissue section of breast cancer) to determine whether or not pathological complete response (pCR) is achieved when preoperative chemotherapy using anticancer drugs is performed ) Is used to provide a means (inspection support method) for prediction. [1] A step of obtaining a fluorescent image of a breast cancer tissue section in which bright spots of fluorescent nanoparticles labeled with one or more kinds of breast cancer-related proteins are represented, [2] based on the bright spots of the fluorescent images. And obtaining one or more types of indices relating to the expression level of the breast cancer-related protein, and [3] obtaining information for predicting pCR by analysis using the one or more kinds of indices. Inspection support method. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020050373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022196203-A1 |
| priorityDate |
2016-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |